Administration of traditional Chinese medicine "supports" overseas sales of traditional Chinese Medicine

Wang Lian, director of the office of the State Administration of traditional Chinese medicine, said at a regular press conference held today by the national health and family planning commission that "Britain has some problems with Chinese traditional medicine, especially Chinese patent medicine, because its testing standards are different from domestic standards." Wang Lian said that the administration of traditional Chinese medicine should strengthen its efforts in the standardization construction of traditional Chinese medicine, especially traditional Chinese medicine, and establish a scientific standard of traditional Chinese medicine that can meet international standards The national health and Family Planning Commission held a regular press conference on the morning of the 10th to introduce the development of China's floating population in 2013 and the relevant information about the integration of TCM health management services into the national basic public health services At the meeting, the head of the national administration of traditional Chinese medicine answered questions about the UK's plans to ban the sale of proprietary Chinese medicine in the UK from next year and the frequent obstacles in the process of internationalization of traditional Chinese medicine Previously, the UK drug administration informed the TCM societies and some large TCM stores to report the inventory of Chinese patent medicines The agency said it planned to ban the sale of Chinese patent medicines in the UK from the beginning of next year At present, the retail revenue of Chinese patent medicine accounts for about 30-40% of all clinics If this regulation is implemented, it will undoubtedly bring a disaster to the British traditional Chinese medicine industry, and a large number of clinics will be closed down In this regard, the reporter once learned from Yunnan Baiyao (000538 SZ), Tongrentang (600085 SH), Pianzihuang (600436 SH) and other listed companies of traditional Chinese medicine that at present, the proportion of export trade of traditional Chinese medicine in the company is limited, so the ban will not have a significant impact on the operation and development of the company In May this year, the Ministry of Commerce and the State Administration of traditional Chinese medicine jointly held a press conference to announce the notice on carrying out the construction of key projects, key enterprises and key regions of traditional Chinese medicine service trade It is clear that in the future, a number of key enterprises of traditional Chinese Medicine service trade will be built through fiscal, tax, financial, import and export policies Subsequently, the Ministry of Commerce and the State Administration of traditional Chinese medicine stated in mid August that they would promote the internationalization of traditional Chinese medicine Unexpectedly, the plan has not yet been implemented, so it is in the dilemma of banning the sale of Chinese patent medicines in the UK Wang Lian also said that most of the traditional Chinese medicine depends on natural and wild animals, plants and minerals Some plants are beneficial to human body, but others are harmful to human body We seldom use single medicine to break or take it directly Most of them are prescription and compatibility The purpose is to enhance the curative effect and reduce the side effects There are some measures that a certain Chinese medicine contains toxic ingredients If you take a single medicine, it must be harmful You need to mix it with other drugs This is also a different pharmacological theory between Chinese medicine and Western medicine.